Results
SECONDARY
The secondary analysis included 705 patients (mean [SD] age, 63.0 [9.2] years; 234 females [33.2%] and 471 males [66.8%]) in the efficacy analysis set, of the total 710 patients enrolled in the J-FORCE trial (eFigure 3 in 